Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics

Area of Science:

• Molecular Biology
• Oncology
• Pharmacology

Background:

• The Hippo pathway is a conserved signaling network regulating organ size and development.
• Dysregulation of the Hippo pathway is implicated in various diseases, notably cancer, affecting tumorigenesis and progression.

Purpose of the Study:

• To provide an overview of the Hippo signaling pathway's core components and mechanisms.
• To analyze the link between Hippo signaling and cancer.
• To summarize small molecule inhibitors targeting the Hippo pathway with demonstrated anti-tumor effects.

Main Methods:

• Literature review of Hippo pathway signaling.
• Analysis of the relationship between Hippo pathway dysregulation and cancer.
• Compilation and discussion of small molecule inhibitors targeting the Hippo pathway.

Main Results:

• The Hippo pathway plays a significant role in cell proliferation, apoptosis, and tissue homeostasis.
• Numerous small molecules targeting the Hippo pathway have shown therapeutic potential.
• Some Hippo pathway inhibitors are progressing through clinical trials for cancer treatment.

Conclusions:

• Targeting the Hippo pathway represents a promising strategy for cancer therapy.
• Understanding the structure-activity relationships of small molecule inhibitors is key for developing effective anticancer agents.
• Further research into Hippo pathway modulators could lead to novel cancer treatments.